

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to leptin stimulus (GO:0044320) | 5.54713321 |
| 2 | response to leptin (GO:0044321) | 4.94775585 |
| 3 | fatty acid homeostasis (GO:0055089) | 4.88462612 |
| 4 | NADH metabolic process (GO:0006734) | 4.80676801 |
| 5 | gamma-aminobutyric acid transport (GO:0015812) | 4.64388473 |
| 6 | negative regulation of appetite (GO:0032099) | 4.46767183 |
| 7 | negative regulation of response to food (GO:0032096) | 4.46767183 |
| 8 | transcytosis (GO:0045056) | 4.44029071 |
| 9 | alanine transport (GO:0032328) | 4.32950880 |
| 10 | L-amino acid import (GO:0043092) | 4.31401920 |
| 11 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 4.27770023 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 4.27762629 |
| 13 | amino acid import (GO:0043090) | 4.27027609 |
| 14 | glycerolipid catabolic process (GO:0046503) | 4.23502639 |
| 15 | cellular potassium ion homeostasis (GO:0030007) | 4.18827366 |
| 16 | lipid particle organization (GO:0034389) | 4.17328855 |
| 17 | CDP-diacylglycerol metabolic process (GO:0046341) | 4.08714513 |
| 18 | triglyceride biosynthetic process (GO:0019432) | 4.05828800 |
| 19 | L-serine transport (GO:0015825) | 4.03975572 |
| 20 | C4-dicarboxylate transport (GO:0015740) | 4.01938009 |
| 21 | ethanol oxidation (GO:0006069) | 3.93999507 |
| 22 | sodium ion export (GO:0071436) | 3.87882455 |
| 23 | neutral lipid biosynthetic process (GO:0046460) | 3.81689882 |
| 24 | acylglycerol biosynthetic process (GO:0046463) | 3.81689882 |
| 25 | locomotory exploration behavior (GO:0035641) | 3.77940793 |
| 26 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.77561593 |
| 27 | diacylglycerol metabolic process (GO:0046339) | 3.70745369 |
| 28 | response to phenylpropanoid (GO:0080184) | 3.70282861 |
| 29 | valine metabolic process (GO:0006573) | 3.68881621 |
| 30 | protein heterotrimerization (GO:0070208) | 3.67729945 |
| 31 | thioester biosynthetic process (GO:0035384) | 3.64841120 |
| 32 | acyl-CoA biosynthetic process (GO:0071616) | 3.64841120 |
| 33 | cell communication by electrical coupling (GO:0010644) | 3.62732350 |
| 34 | polyol transport (GO:0015791) | 3.57910502 |
| 35 | positive regulation of fatty acid oxidation (GO:0046321) | 3.55942297 |
| 36 | lipid storage (GO:0019915) | 3.52552152 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.51689786 |
| 38 | fatty acid elongation (GO:0030497) | 3.47311596 |
| 39 | serine transport (GO:0032329) | 3.41984734 |
| 40 | cerebellar granule cell differentiation (GO:0021707) | 3.41068681 |
| 41 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.40829700 |
| 42 | potassium ion import (GO:0010107) | 3.40450075 |
| 43 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.38037092 |
| 44 | triglyceride metabolic process (GO:0006641) | 3.37584984 |
| 45 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.36800649 |
| 46 | regulation of response to food (GO:0032095) | 3.35860780 |
| 47 | phagocytosis, recognition (GO:0006910) | 3.31798726 |
| 48 | cellular sodium ion homeostasis (GO:0006883) | 3.31756238 |
| 49 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.30874954 |
| 50 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.30341225 |
| 51 | cGMP-mediated signaling (GO:0019934) | 3.27517682 |
| 52 | tricarboxylic acid metabolic process (GO:0072350) | 3.24961213 |
| 53 | neurotransmitter uptake (GO:0001504) | 3.24442988 |
| 54 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.21837066 |
| 55 | ethanol metabolic process (GO:0006067) | 3.20285170 |
| 56 | detection of calcium ion (GO:0005513) | 3.18051890 |
| 57 | oxaloacetate metabolic process (GO:0006107) | 3.17243796 |
| 58 | positive regulation of cholesterol efflux (GO:0010875) | 3.13867130 |
| 59 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.13713743 |
| 60 | negative regulation of astrocyte differentiation (GO:0048712) | 3.13123890 |
| 61 | acylglycerol metabolic process (GO:0006639) | 3.13024906 |
| 62 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.10772616 |
| 63 | fatty acid transmembrane transport (GO:1902001) | 3.07674639 |
| 64 | neutral lipid metabolic process (GO:0006638) | 3.07638388 |
| 65 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.06994285 |
| 66 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.05411144 |
| 67 | hyperosmotic salinity response (GO:0042538) | 3.05303428 |
| 68 | positive regulation of lipid storage (GO:0010884) | 3.04167717 |
| 69 | low-density lipoprotein particle clearance (GO:0034383) | 3.03358234 |
| 70 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.01235524 |
| 71 | negative regulation of amino acid transport (GO:0051956) | 3.01166499 |
| 72 | thioester metabolic process (GO:0035383) | 3.00940280 |
| 73 | acyl-CoA metabolic process (GO:0006637) | 3.00940280 |
| 74 | primary alcohol metabolic process (GO:0034308) | 2.99979931 |
| 75 | response to dietary excess (GO:0002021) | 2.99630940 |
| 76 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.97556015 |
| 77 | glutamate receptor signaling pathway (GO:0007215) | 2.96367162 |
| 78 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.95897071 |
| 79 | proline transport (GO:0015824) | 2.94864934 |
| 80 | kidney mesenchyme development (GO:0072074) | 2.93494404 |
| 81 | potassium ion homeostasis (GO:0055075) | 2.91266314 |
| 82 | linoleic acid metabolic process (GO:0043651) | 2.90375869 |
| 83 | positive regulation of glomerulus development (GO:0090193) | 2.90141465 |
| 84 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.89986993 |
| 85 | plasma lipoprotein particle clearance (GO:0034381) | 2.89886809 |
| 86 | pattern specification involved in kidney development (GO:0061004) | 2.89165956 |
| 87 | positive regulation of sterol transport (GO:0032373) | 2.89111934 |
| 88 | positive regulation of cholesterol transport (GO:0032376) | 2.89111934 |
| 89 | response to nitrosative stress (GO:0051409) | 2.87081711 |
| 90 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.86845447 |
| 91 | neuron cell-cell adhesion (GO:0007158) | 2.86763998 |
| 92 | regulation of sequestering of triglyceride (GO:0010889) | 2.86637360 |
| 93 | cellular response to cadmium ion (GO:0071276) | 2.86420782 |
| 94 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.85355825 |
| 95 | ovulation from ovarian follicle (GO:0001542) | 2.84662509 |
| 96 | dermatan sulfate metabolic process (GO:0030205) | 2.81720627 |
| 97 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.80855053 |
| 98 | phosphatidic acid metabolic process (GO:0046473) | 2.79548500 |
| 99 | phosphatidic acid biosynthetic process (GO:0006654) | 2.79548500 |
| 100 | chondroitin sulfate catabolic process (GO:0030207) | 2.76607574 |
| 101 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.75965542 |
| 102 | dermatan sulfate biosynthetic process (GO:0030208) | 2.75901853 |
| 103 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.75431884 |
| 104 | primary alcohol catabolic process (GO:0034310) | 2.75424920 |
| 105 | positive regulation of vascular permeability (GO:0043117) | 2.73478565 |
| 106 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.73443836 |
| 107 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.72605337 |
| 108 | white fat cell differentiation (GO:0050872) | 2.72148580 |
| 109 | synaptic transmission, glutamatergic (GO:0035249) | 2.71886963 |
| 110 | retinol metabolic process (GO:0042572) | 2.70832713 |
| 111 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.70440018 |
| 112 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.69867916 |
| 113 | postsynaptic membrane organization (GO:0001941) | 2.69031912 |
| 114 | response to auditory stimulus (GO:0010996) | 2.68992975 |
| 115 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.67914729 |
| 116 | glycine transport (GO:0015816) | 2.67583730 |
| 117 | myelination in peripheral nervous system (GO:0022011) | 2.67395277 |
| 118 | peripheral nervous system axon ensheathment (GO:0032292) | 2.67395277 |
| 119 | regulation of gonadotropin secretion (GO:0032276) | 2.67123235 |
| 120 | central nervous system myelination (GO:0022010) | 2.66470727 |
| 121 | axon ensheathment in central nervous system (GO:0032291) | 2.66470727 |
| 122 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.65823629 |
| 123 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.65654190 |
| 124 | regulation of membrane repolarization (GO:0060306) | 2.65553271 |
| 125 | protein localization to cell surface (GO:0034394) | 2.65388105 |
| 126 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.65341929 |
| 127 | vocalization behavior (GO:0071625) | 2.63917473 |
| 128 | neuronal action potential propagation (GO:0019227) | 2.63558071 |
| 129 | synaptic vesicle exocytosis (GO:0016079) | 2.63424333 |
| 130 | import into cell (GO:0098657) | 2.62603992 |
| 131 | tricarboxylic acid cycle (GO:0006099) | 2.62533817 |
| 132 | regulation of cell communication by electrical coupling (GO:0010649) | 2.60566074 |
| 133 | auditory behavior (GO:0031223) | 2.59771781 |
| 134 | cAMP biosynthetic process (GO:0006171) | 2.59702343 |
| 135 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.58951297 |
| 136 | glomerular filtration (GO:0003094) | 2.58785809 |
| 137 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.57690641 |
| 138 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.57327269 |
| 139 | fatty acid beta-oxidation (GO:0006635) | 2.57184405 |
| 140 | acetyl-CoA metabolic process (GO:0006084) | 2.57148070 |
| 141 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.56677570 |
| 142 | acidic amino acid transport (GO:0015800) | 2.56609760 |
| 143 | brown fat cell differentiation (GO:0050873) | 2.56519758 |
| 144 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.55947892 |
| 145 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.55466671 |
| 146 | regulation of cilium movement (GO:0003352) | 2.54106561 |
| 147 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.53078515 |
| 148 | regulation of phospholipase A2 activity (GO:0032429) | 2.51878455 |
| 149 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.50731025 |
| 150 | response to epinephrine (GO:0071871) | 2.50561740 |
| 151 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.50151448 |
| 152 | dendrite morphogenesis (GO:0048813) | 2.47276234 |
| 153 | biotin metabolic process (GO:0006768) | 2.46585457 |
| 154 | transmission of nerve impulse (GO:0019226) | 2.45954391 |
| 155 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.45284535 |
| 156 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.44643969 |
| 157 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.43832465 |
| 158 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.42607384 |
| 159 | triglyceride catabolic process (GO:0019433) | 2.41898556 |
| 160 | cellular response to cholesterol (GO:0071397) | 2.41685583 |
| 161 | acylglycerol catabolic process (GO:0046464) | 2.40778463 |
| 162 | neutral lipid catabolic process (GO:0046461) | 2.40778463 |
| 163 | neurotransmitter secretion (GO:0007269) | 2.40488991 |
| 164 | positive regulation of macrophage cytokine production (GO:0060907) | 2.40195592 |
| 165 | regulation of fatty acid oxidation (GO:0046320) | 2.40189616 |
| 166 | layer formation in cerebral cortex (GO:0021819) | 2.39565805 |
| 167 | regulation of astrocyte differentiation (GO:0048710) | 2.37617328 |
| 168 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.36089924 |
| 169 | regulation of beta-amyloid formation (GO:1902003) | 2.35697140 |
| 170 | regulation of synapse structural plasticity (GO:0051823) | 2.35158234 |
| 171 | negative regulation of sodium ion transport (GO:0010766) | 2.34333279 |
| 172 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.34318165 |
| 173 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.31946737 |
| 174 | cellular response to epinephrine stimulus (GO:0071872) | 2.31200137 |
| 175 | atrial cardiac muscle cell action potential (GO:0086014) | 2.30089457 |
| 176 | low-density lipoprotein particle remodeling (GO:0034374) | 2.29698811 |
| 177 | regulation of cholesterol storage (GO:0010885) | 2.27467640 |
| 178 | positive regulation of glucose import (GO:0046326) | 2.27454169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.52722994 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.16644055 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.14499474 |
| 4 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.87049836 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.83597852 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.83553518 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.82249911 |
| 8 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.74508835 |
| 9 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.64840205 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61707945 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61707945 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.61258118 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.58505462 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.43154898 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.41338825 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.36542411 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.27429665 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.24380930 |
| 19 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.10380688 |
| 20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.06412896 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02543572 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.96693842 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.93349168 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.88958539 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.88923390 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.86125084 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.82603193 |
| 28 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.76525195 |
| 29 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.76525195 |
| 30 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.76361969 |
| 31 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76346277 |
| 32 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.75570930 |
| 33 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66777032 |
| 34 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.65699056 |
| 35 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.62359901 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61734457 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57657606 |
| 38 | RXR_22108803_ChIP-Seq_LS180_Human | 1.55027604 |
| 39 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.51664868 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.48228336 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.47948949 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47355648 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46746037 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46414528 |
| 45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.44171184 |
| 46 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.44168728 |
| 47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.42900843 |
| 48 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40552891 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38676326 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38662957 |
| 51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37273274 |
| 52 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37229010 |
| 53 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.36222982 |
| 54 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.35570922 |
| 55 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.35242402 |
| 56 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.33988635 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.33501726 |
| 58 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.33288394 |
| 59 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.32447466 |
| 60 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.32447466 |
| 61 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.32447466 |
| 62 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.30703006 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29450203 |
| 64 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27634548 |
| 65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27144489 |
| 66 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25838160 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25154261 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24389125 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23659120 |
| 70 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23420240 |
| 71 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21434786 |
| 72 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20257222 |
| 73 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19282636 |
| 74 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.19072405 |
| 75 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18330821 |
| 76 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18317892 |
| 77 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.17754445 |
| 78 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15075514 |
| 79 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14874563 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14195252 |
| 81 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.13750747 |
| 82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.13044663 |
| 83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12891238 |
| 84 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.12543911 |
| 85 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11418717 |
| 86 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.10973968 |
| 87 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.10960507 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10225910 |
| 89 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09688535 |
| 90 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.08965045 |
| 91 | AR_19668381_ChIP-Seq_PC3_Human | 1.08534718 |
| 92 | TP53_16413492_ChIP-PET_HCT116_Human | 1.07859779 |
| 93 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.07510080 |
| 94 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07380881 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07289862 |
| 96 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.06459923 |
| 97 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.04637974 |
| 98 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04388328 |
| 99 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02860002 |
| 100 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02429697 |
| 101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02408947 |
| 102 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.02176312 |
| 103 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01711734 |
| 104 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.00958505 |
| 105 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.00081488 |
| 106 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98724891 |
| 107 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.98648691 |
| 108 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97574185 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97382642 |
| 110 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96952557 |
| 111 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.95857678 |
| 112 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95837733 |
| 113 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95686029 |
| 114 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95624675 |
| 115 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95624675 |
| 116 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95288502 |
| 117 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94482507 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94426043 |
| 119 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.94051117 |
| 120 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92801881 |
| 121 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92718282 |
| 122 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91822384 |
| 123 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.90991587 |
| 124 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90971605 |
| 125 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90924669 |
| 126 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90478021 |
| 127 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90112005 |
| 128 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.89835779 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89224186 |
| 130 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88302922 |
| 131 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88094120 |
| 132 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87874843 |
| 133 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87599391 |
| 134 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.87356698 |
| 135 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.86653832 |
| 136 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.85728946 |
| 137 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.84680837 |
| 138 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83943369 |
| 139 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.82949350 |
| 140 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81433976 |
| 141 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80269880 |
| 142 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80225112 |
| 143 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.80225112 |
| 144 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.79516412 |
| 145 | VDR_22108803_ChIP-Seq_LS180_Human | 0.77789394 |
| 146 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.77086571 |
| 147 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.76202340 |
| 148 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.75783650 |
| 149 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.75192939 |
| 150 | CBP_21632823_ChIP-Seq_H3396_Human | 0.74099665 |
| 151 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.72477727 |
| 152 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.72474842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 4.32786857 |
| 2 | MP0004130_abnormal_muscle_cell | 3.49451666 |
| 3 | MP0003690_abnormal_glial_cell | 3.13443154 |
| 4 | MP0005666_abnormal_adipose_tissue | 2.68994741 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 2.68167774 |
| 6 | MP0005503_abnormal_tendon_morphology | 2.58282829 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 2.57002234 |
| 8 | MP0001501_abnormal_sleep_pattern | 2.51570621 |
| 9 | MP0003011_delayed_dark_adaptation | 2.36924053 |
| 10 | MP0009046_muscle_twitch | 2.31555056 |
| 11 | MP0000013_abnormal_adipose_tissue | 2.29752337 |
| 12 | MP0004885_abnormal_endolymph | 2.26172829 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.21156517 |
| 14 | MP0004185_abnormal_adipocyte_glucose | 2.11244117 |
| 15 | MP0001486_abnormal_startle_reflex | 2.08195727 |
| 16 | MP0003186_abnormal_redox_activity | 1.99522055 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 1.99408848 |
| 18 | MP0005375_adipose_tissue_phenotype | 1.94998871 |
| 19 | MP0002970_abnormal_white_adipose | 1.93624600 |
| 20 | MP0009745_abnormal_behavioral_response | 1.90754277 |
| 21 | MP0005423_abnormal_somatic_nervous | 1.88989665 |
| 22 | MP0005275_abnormal_skin_tensile | 1.87010971 |
| 23 | MP0003959_abnormal_lean_body | 1.82253195 |
| 24 | MP0003646_muscle_fatigue | 1.81027391 |
| 25 | MP0008569_lethality_at_weaning | 1.78780276 |
| 26 | * MP0004215_abnormal_myocardial_fiber | 1.76774603 |
| 27 | MP0002064_seizures | 1.76433059 |
| 28 | MP0000751_myopathy | 1.72279893 |
| 29 | MP0004270_analgesia | 1.71351634 |
| 30 | MP0004858_abnormal_nervous_system | 1.70381698 |
| 31 | MP0002272_abnormal_nervous_system | 1.70057209 |
| 32 | MP0002108_abnormal_muscle_morphology | 1.68020396 |
| 33 | MP0002063_abnormal_learning/memory/cond | 1.62925053 |
| 34 | MP0005377_hearing/vestibular/ear_phenot | 1.61388630 |
| 35 | MP0003878_abnormal_ear_physiology | 1.61388630 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 1.61335675 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.60558670 |
| 38 | MP0003136_yellow_coat_color | 1.60250218 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.58798039 |
| 40 | MP0001440_abnormal_grooming_behavior | 1.58699658 |
| 41 | MP0003880_abnormal_central_pattern | 1.56090108 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.54387568 |
| 43 | MP0002971_abnormal_brown_adipose | 1.51243867 |
| 44 | MP0005171_absent_coat_pigmentation | 1.50972831 |
| 45 | MP0003633_abnormal_nervous_system | 1.50183774 |
| 46 | MP0002254_reproductive_system_inflammat | 1.48665472 |
| 47 | MP0003329_amyloid_beta_deposits | 1.47538148 |
| 48 | MP0009384_cardiac_valve_regurgitation | 1.44938004 |
| 49 | MP0000003_abnormal_adipose_tissue | 1.44309384 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 1.42388131 |
| 51 | MP0004084_abnormal_cardiac_muscle | 1.41194343 |
| 52 | MP0002734_abnormal_mechanical_nocicepti | 1.40334773 |
| 53 | MP0001502_abnormal_circadian_rhythm | 1.39438659 |
| 54 | MP0003279_aneurysm | 1.36772022 |
| 55 | MP0005452_abnormal_adipose_tissue | 1.34774396 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.32277254 |
| 57 | MP0005448_abnormal_energy_balance | 1.31206448 |
| 58 | MP0005385_cardiovascular_system_phenoty | 1.28456356 |
| 59 | MP0001544_abnormal_cardiovascular_syste | 1.28456356 |
| 60 | MP0009379_abnormal_foot_pigmentation | 1.28251831 |
| 61 | MP0002295_abnormal_pulmonary_circulatio | 1.28241557 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 1.28069254 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 1.27765785 |
| 64 | MP0001485_abnormal_pinna_reflex | 1.27402144 |
| 65 | MP0001968_abnormal_touch/_nociception | 1.26959646 |
| 66 | MP0010368_abnormal_lymphatic_system | 1.25522039 |
| 67 | MP0002909_abnormal_adrenal_gland | 1.25020306 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 1.23648708 |
| 69 | MP0002736_abnormal_nociception_after | 1.22893854 |
| 70 | MP0001881_abnormal_mammary_gland | 1.19616647 |
| 71 | MP0002733_abnormal_thermal_nociception | 1.18016914 |
| 72 | MP0003137_abnormal_impulse_conducting | 1.17620224 |
| 73 | MP0002090_abnormal_vision | 1.16368179 |
| 74 | MP0000759_abnormal_skeletal_muscle | 1.15857447 |
| 75 | MP0000747_muscle_weakness | 1.15336043 |
| 76 | MP0003634_abnormal_glial_cell | 1.15273445 |
| 77 | MP0010329_abnormal_lipoprotein_level | 1.14667787 |
| 78 | MP0005620_abnormal_muscle_contractility | 1.13551912 |
| 79 | MP0006138_congestive_heart_failure | 1.13468744 |
| 80 | MP0003950_abnormal_plasma_membrane | 1.12595502 |
| 81 | MP0008438_abnormal_cutaneous_collagen | 1.11752697 |
| 82 | MP0004272_abnormal_basement_membrane | 1.11618044 |
| 83 | MP0009115_abnormal_fat_cell | 1.11442535 |
| 84 | MP0003828_pulmonary_edema | 1.09136418 |
| 85 | MP0003631_nervous_system_phenotype | 1.09007289 |
| 86 | MP0004233_abnormal_muscle_weight | 1.08829247 |
| 87 | MP0004036_abnormal_muscle_relaxation | 1.08172362 |
| 88 | MP0005535_abnormal_body_temperature | 1.06828348 |
| 89 | MP0000778_abnormal_nervous_system | 1.05752771 |
| 90 | MP0005595_abnormal_vascular_smooth | 1.04414000 |
| 91 | MP0002557_abnormal_social/conspecific_i | 1.04198814 |
| 92 | MP0004924_abnormal_behavior | 1.03553509 |
| 93 | MP0005386_behavior/neurological_phenoty | 1.03553509 |
| 94 | MP0001970_abnormal_pain_threshold | 1.03061722 |
| 95 | MP0004147_increased_porphyrin_level | 1.01890317 |
| 96 | MP0001661_extended_life_span | 1.00127111 |
| 97 | MP0005379_endocrine/exocrine_gland_phen | 0.96825349 |
| 98 | MP0005334_abnormal_fat_pad | 0.95908861 |
| 99 | MP0000920_abnormal_myelination | 0.94435563 |
| 100 | MP0001727_abnormal_embryo_implantation | 0.94255351 |
| 101 | MP0002972_abnormal_cardiac_muscle | 0.94003108 |
| 102 | MP0004742_abnormal_vestibular_system | 0.93974824 |
| 103 | MP0000750_abnormal_muscle_regeneration | 0.93801762 |
| 104 | * MP0000343_altered_response_to | 0.93427022 |
| 105 | MP0004484_altered_response_of | 0.91214591 |
| 106 | MP0002078_abnormal_glucose_homeostasis | 0.90446449 |
| 107 | MP0003705_abnormal_hypodermis_morpholog | 0.90353394 |
| 108 | MP0006276_abnormal_autonomic_nervous | 0.90130286 |
| 109 | MP0004142_abnormal_muscle_tone | 0.89990784 |
| 110 | MP0001177_atelectasis | 0.89117793 |
| 111 | MP0005623_abnormal_meninges_morphology | 0.88833973 |
| 112 | MP0002066_abnormal_motor_capabilities/c | 0.87340349 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87001787 |
| 114 | MP0002118_abnormal_lipid_homeostasis | 0.85959270 |
| 115 | MP0008775_abnormal_heart_ventricle | 0.85900561 |
| 116 | MP0003075_altered_response_to | 0.85650780 |
| 117 | MP0005369_muscle_phenotype | 0.84159909 |
| 118 | MP0005164_abnormal_response_to | 0.82690943 |
| 119 | MP0005165_increased_susceptibility_to | 0.82350793 |
| 120 | MP0002133_abnormal_respiratory_system | 0.81561086 |
| 121 | MP0005388_respiratory_system_phenotype | 0.81561086 |
| 122 | MP0003868_abnormal_feces_composition | 0.79894920 |
| 123 | MP0000749_muscle_degeneration | 0.79684049 |
| 124 | MP0004087_abnormal_muscle_fiber | 0.77537273 |
| 125 | MP0005508_abnormal_skeleton_morphology | 0.77115123 |
| 126 | MP0001879_abnormal_lymphatic_vessel | 0.77037025 |
| 127 | MP0001963_abnormal_hearing_physiology | 0.76297175 |
| 128 | MP0002184_abnormal_innervation | 0.75843672 |
| 129 | MP0002089_abnormal_postnatal_growth/wei | 0.75682201 |
| 130 | MP0001299_abnormal_eye_distance/ | 0.75486833 |
| 131 | MP0000604_amyloidosis | 0.74912038 |
| 132 | MP0004085_abnormal_heartbeat | 0.74898724 |
| 133 | MP0005647_abnormal_sex_gland | 0.74313973 |
| 134 | MP0001984_abnormal_olfaction | 0.74302822 |
| 135 | MP0001958_emphysema | 0.74066701 |
| 136 | MP0005551_abnormal_eye_electrophysiolog | 0.73384685 |
| 137 | MP0002269_muscular_atrophy | 0.70385635 |
| 138 | MP0005330_cardiomyopathy | 0.66607112 |
| 139 | MP0003879_abnormal_hair_cell | 0.66222522 |
| 140 | MP0000230_abnormal_systemic_arterial | 0.64619069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplasia involving bones of the upper limbs (HP:0009823) | 6.34353761 |
| 2 | Aplasia of the phalanges of the hand (HP:0009802) | 6.34353761 |
| 3 | Aplasia involving bones of the extremities (HP:0009825) | 6.34353761 |
| 4 | Muscle fiber splitting (HP:0003555) | 4.58971411 |
| 5 | Focal motor seizures (HP:0011153) | 4.22884439 |
| 6 | Abnormality of secondary sexual hair (HP:0009888) | 4.13338718 |
| 7 | Abnormality of the axillary hair (HP:0100134) | 4.13338718 |
| 8 | Hemiplegia (HP:0002301) | 4.10492752 |
| 9 | Hemiparesis (HP:0001269) | 3.83968638 |
| 10 | Diplopia (HP:0000651) | 3.51057380 |
| 11 | Abnormality of binocular vision (HP:0011514) | 3.51057380 |
| 12 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.41022788 |
| 13 | Oligomenorrhea (HP:0000876) | 3.40907206 |
| 14 | Action tremor (HP:0002345) | 3.35703729 |
| 15 | Acanthosis nigricans (HP:0000956) | 3.35429560 |
| 16 | Exercise-induced myalgia (HP:0003738) | 3.30976486 |
| 17 | Bone cyst (HP:0012062) | 3.24774591 |
| 18 | Neck muscle weakness (HP:0000467) | 3.18862272 |
| 19 | Megalencephaly (HP:0001355) | 3.18643129 |
| 20 | Increased serum pyruvate (HP:0003542) | 3.12114934 |
| 21 | Polyphagia (HP:0002591) | 3.07878975 |
| 22 | Spinal rigidity (HP:0003306) | 3.04317966 |
| 23 | Insulin resistance (HP:0000855) | 3.02077711 |
| 24 | Increased muscle lipid content (HP:0009058) | 2.94100572 |
| 25 | Axonal loss (HP:0003447) | 2.94006445 |
| 26 | Short hallux (HP:0010109) | 2.93616169 |
| 27 | Protrusio acetabuli (HP:0003179) | 2.90365133 |
| 28 | Abnormality of glycolysis (HP:0004366) | 2.85247355 |
| 29 | Hyporeflexia of lower limbs (HP:0002600) | 2.84677831 |
| 30 | Focal seizures (HP:0007359) | 2.82073618 |
| 31 | Tetraparesis (HP:0002273) | 2.80964068 |
| 32 | Increased connective tissue (HP:0009025) | 2.78436646 |
| 33 | Neurofibrillary tangles (HP:0002185) | 2.76737583 |
| 34 | Progressive cerebellar ataxia (HP:0002073) | 2.75016587 |
| 35 | Skin nodule (HP:0200036) | 2.74005164 |
| 36 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.73572323 |
| 37 | Difficulty running (HP:0009046) | 2.73251373 |
| 38 | Hypoplastic left heart (HP:0004383) | 2.73100739 |
| 39 | Hypoalphalipoproteinemia (HP:0003233) | 2.71708176 |
| 40 | Potter facies (HP:0002009) | 2.70186309 |
| 41 | Facial shape deformation (HP:0011334) | 2.70186309 |
| 42 | Myokymia (HP:0002411) | 2.69532043 |
| 43 | Dysdiadochokinesis (HP:0002075) | 2.65548978 |
| 44 | Abnormal eating behavior (HP:0100738) | 2.65493945 |
| 45 | Fibular aplasia (HP:0002990) | 2.64152519 |
| 46 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.62950255 |
| 47 | Complement deficiency (HP:0004431) | 2.57903643 |
| 48 | Onycholysis (HP:0001806) | 2.51901853 |
| 49 | Lipoatrophy (HP:0100578) | 2.50516816 |
| 50 | Humeroradial synostosis (HP:0003041) | 2.43168810 |
| 51 | Synostosis involving the elbow (HP:0003938) | 2.43168810 |
| 52 | Growth hormone excess (HP:0000845) | 2.42504521 |
| 53 | Polar cataract (HP:0010696) | 2.41857660 |
| 54 | Adactyly (HP:0009776) | 2.41238073 |
| 55 | Prominent supraorbital ridges (HP:0000336) | 2.39664910 |
| 56 | Broad metatarsal (HP:0001783) | 2.38944361 |
| 57 | Type 1 muscle fiber predominance (HP:0003803) | 2.35838790 |
| 58 | Hyperglycinuria (HP:0003108) | 2.32579509 |
| 59 | Foot dorsiflexor weakness (HP:0009027) | 2.29681355 |
| 60 | Bundle branch block (HP:0011710) | 2.28913972 |
| 61 | Rimmed vacuoles (HP:0003805) | 2.27992489 |
| 62 | Hypercortisolism (HP:0001578) | 2.26822240 |
| 63 | Generalized tonic-clonic seizures (HP:0002069) | 2.26341497 |
| 64 | Epileptic encephalopathy (HP:0200134) | 2.25800840 |
| 65 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.25509045 |
| 66 | Visual hallucinations (HP:0002367) | 2.24782554 |
| 67 | Abnormal atrioventricular conduction (HP:0005150) | 2.24466044 |
| 68 | Abnormality of the foot musculature (HP:0001436) | 2.24298722 |
| 69 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.24169582 |
| 70 | Heart block (HP:0012722) | 2.23869872 |
| 71 | Hypertriglyceridemia (HP:0002155) | 2.23740354 |
| 72 | Maternal diabetes (HP:0009800) | 2.23354187 |
| 73 | Absent hair (HP:0002298) | 2.21952636 |
| 74 | Myoglobinuria (HP:0002913) | 2.19130176 |
| 75 | Intention tremor (HP:0002080) | 2.18341476 |
| 76 | Bradycardia (HP:0001662) | 2.18070624 |
| 77 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.17204668 |
| 78 | Myocardial infarction (HP:0001658) | 2.16895038 |
| 79 | Gowers sign (HP:0003391) | 2.16587234 |
| 80 | Subcapsular cataract (HP:0000523) | 2.11641398 |
| 81 | Rhabdomyolysis (HP:0003201) | 2.11347201 |
| 82 | Myotonia (HP:0002486) | 2.10814503 |
| 83 | Rhinitis (HP:0012384) | 2.10590542 |
| 84 | Opisthotonus (HP:0002179) | 2.10157101 |
| 85 | Back pain (HP:0003418) | 2.08707970 |
| 86 | Cerebral inclusion bodies (HP:0100314) | 2.08173188 |
| 87 | EMG: myopathic abnormalities (HP:0003458) | 2.07766277 |
| 88 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.06715508 |
| 89 | Frequent falls (HP:0002359) | 2.06693760 |
| 90 | Retinal atrophy (HP:0001105) | 2.06277363 |
| 91 | Epidermoid cyst (HP:0200040) | 2.05337056 |
| 92 | Ketoacidosis (HP:0001993) | 2.03668129 |
| 93 | Dysmetria (HP:0001310) | 2.01122124 |
| 94 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.00984797 |
| 95 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.00539802 |
| 96 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.00539802 |
| 97 | Hypoplastic heart (HP:0001961) | 1.99506633 |
| 98 | Ectopia lentis (HP:0001083) | 1.99435574 |
| 99 | Long nose (HP:0003189) | 1.99423739 |
| 100 | Postural instability (HP:0002172) | 1.98935676 |
| 101 | Turricephaly (HP:0000262) | 1.97864481 |
| 102 | Abnormality of complement system (HP:0005339) | 1.95146902 |
| 103 | Atrial fibrillation (HP:0005110) | 1.94686910 |
| 104 | Exercise-induced muscle cramps (HP:0003710) | 1.90771177 |
| 105 | Gaze-evoked nystagmus (HP:0000640) | 1.90740683 |
| 106 | Increased variability in muscle fiber diameter (HP:0003557) | 1.90538537 |
| 107 | Truncal ataxia (HP:0002078) | 1.89297578 |
| 108 | Scanning speech (HP:0002168) | 1.88677893 |
| 109 | Muscle stiffness (HP:0003552) | 1.88196646 |
| 110 | Absent toe (HP:0010760) | 1.88183189 |
| 111 | Supranuclear gaze palsy (HP:0000605) | 1.88003785 |
| 112 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.86864601 |
| 113 | Abnormality of glycine metabolism (HP:0010895) | 1.86864601 |
| 114 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.86785841 |
| 115 | Clumsiness (HP:0002312) | 1.86765119 |
| 116 | Limb-girdle muscle weakness (HP:0003325) | 1.86508023 |
| 117 | Large hands (HP:0001176) | 1.86188155 |
| 118 | Broad hallux (HP:0010055) | 1.85593017 |
| 119 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.85507202 |
| 120 | Narrow nasal bridge (HP:0000446) | 1.85244314 |
| 121 | Shallow orbits (HP:0000586) | 1.85051926 |
| 122 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.83687088 |
| 123 | Hyperventilation (HP:0002883) | 1.82769994 |
| 124 | Tetraplegia (HP:0002445) | 1.82039429 |
| 125 | Long foot (HP:0001833) | 1.81613810 |
| 126 | Mixed hearing impairment (HP:0000410) | 1.81591922 |
| 127 | Gait imbalance (HP:0002141) | 1.81575569 |
| 128 | Infantile muscular hypotonia (HP:0008947) | 1.81506524 |
| 129 | Atonic seizures (HP:0010819) | 1.80928368 |
| 130 | Poor eye contact (HP:0000817) | 1.80151100 |
| 131 | Asymmetric septal hypertrophy (HP:0001670) | 1.80069091 |
| 132 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.80017706 |
| 133 | Spastic diplegia (HP:0001264) | 1.79889886 |
| 134 | Nausea (HP:0002018) | 1.79742301 |
| 135 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.79327170 |
| 136 | Febrile seizures (HP:0002373) | 1.79292340 |
| 137 | Dysmetric saccades (HP:0000641) | 1.77246061 |
| 138 | Abnormality of nail color (HP:0100643) | 1.77094599 |
| 139 | Absent/shortened dynein arms (HP:0200106) | 1.76846357 |
| 140 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.76846357 |
| 141 | Dilated cardiomyopathy (HP:0001644) | 1.76610160 |
| 142 | Metaphyseal dysplasia (HP:0100255) | 1.76446719 |
| 143 | Amyloidosis (HP:0011034) | 1.76350265 |
| 144 | Vertebral compression fractures (HP:0002953) | 1.76333913 |
| 145 | Tubulointerstitial fibrosis (HP:0005576) | 1.76172496 |
| 146 | Prolonged QT interval (HP:0001657) | 1.74786514 |
| 147 | Broad foot (HP:0001769) | 1.74187479 |
| 148 | Xanthomatosis (HP:0000991) | 1.73720783 |
| 149 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.73325623 |
| 150 | Primary atrial arrhythmia (HP:0001692) | 1.73271568 |
| 151 | Thyroid-stimulating hormone excess (HP:0002925) | 1.73105427 |
| 152 | Pheochromocytoma (HP:0002666) | 1.72867636 |
| 153 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.72132051 |
| 154 | Lower limb muscle weakness (HP:0007340) | 1.71966706 |
| 155 | Hypoglycemic coma (HP:0001325) | 1.71561031 |
| 156 | Hypercholesterolemia (HP:0003124) | 1.71503546 |
| 157 | Broad-based gait (HP:0002136) | 1.69885232 |
| 158 | Abnormal urine output (HP:0012590) | 1.69682524 |
| 159 | Accelerated skeletal maturation (HP:0005616) | 1.69608800 |
| 160 | Aortic aneurysm (HP:0004942) | 1.69593210 |
| 161 | Atrioventricular block (HP:0001678) | 1.69384312 |
| 162 | Prenatal maternal abnormality (HP:0002686) | 1.68783669 |
| 163 | Sudden death (HP:0001699) | 1.68729266 |
| 164 | Abnormal social behavior (HP:0012433) | 1.68725644 |
| 165 | Impaired social interactions (HP:0000735) | 1.68725644 |
| 166 | Supraventricular arrhythmia (HP:0005115) | 1.67954647 |
| 167 | Scapular winging (HP:0003691) | 1.67385778 |
| 168 | Muscle fiber inclusion bodies (HP:0100299) | 1.67097793 |
| 169 | Hyperlipoproteinemia (HP:0010980) | 1.67007189 |
| 170 | Anxiety (HP:0000739) | 1.66706162 |
| 171 | Chronic bronchitis (HP:0004469) | 1.65995304 |
| 172 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.65617811 |
| 173 | Abnormal drinking behavior (HP:0030082) | 1.65303076 |
| 174 | Polydipsia (HP:0001959) | 1.65303076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 4.43802125 |
| 2 | MUSK | 3.90159616 |
| 3 | LMTK2 | 3.41423167 |
| 4 | PHKG2 | 3.40519965 |
| 5 | PHKG1 | 3.40519965 |
| 6 | TRIB3 | 3.13699991 |
| 7 | CAMK1D | 2.86199235 |
| 8 | CAMK1G | 2.56899617 |
| 9 | NTRK2 | 2.51984186 |
| 10 | ERBB4 | 2.50011380 |
| 11 | CASK | 2.42355448 |
| 12 | MAPK15 | 2.29646430 |
| 13 | DDR2 | 2.27709495 |
| 14 | SIK1 | 2.27520728 |
| 15 | NTRK3 | 2.21826169 |
| 16 | EPHA4 | 2.21070271 |
| 17 | ABL2 | 2.14853763 |
| 18 | LATS2 | 1.77012827 |
| 19 | TTK | 1.65810624 |
| 20 | TESK1 | 1.65497453 |
| 21 | MAP3K4 | 1.64806936 |
| 22 | ARAF | 1.63857553 |
| 23 | RIPK1 | 1.54115764 |
| 24 | TGFBR2 | 1.53715206 |
| 25 | TYRO3 | 1.48684271 |
| 26 | PNCK | 1.45376269 |
| 27 | PRKD3 | 1.40040701 |
| 28 | EPHB1 | 1.39732591 |
| 29 | INSRR | 1.39481791 |
| 30 | MAP2K7 | 1.37015039 |
| 31 | MAPKAPK3 | 1.33468417 |
| 32 | PRKAA2 | 1.32101857 |
| 33 | MAPK12 | 1.30773854 |
| 34 | PINK1 | 1.29000888 |
| 35 | TSSK6 | 1.26499128 |
| 36 | TIE1 | 1.25526815 |
| 37 | PBK | 1.23843586 |
| 38 | EPHA3 | 1.20400094 |
| 39 | CAMKK2 | 1.20207251 |
| 40 | NTRK1 | 1.18186024 |
| 41 | STK38L | 1.16469043 |
| 42 | MAPK4 | 1.13522100 |
| 43 | MAP2K4 | 1.12804142 |
| 44 | MYLK | 1.10660143 |
| 45 | EPHB2 | 1.09388184 |
| 46 | GRK5 | 1.08572044 |
| 47 | FES | 1.05043928 |
| 48 | MAPK13 | 1.04465236 |
| 49 | MOS | 1.01545674 |
| 50 | PDK2 | 0.98342806 |
| 51 | RIPK4 | 0.98122714 |
| 52 | SGK2 | 0.97320943 |
| 53 | MINK1 | 0.97213856 |
| 54 | STK16 | 0.97042958 |
| 55 | CAMK1 | 0.96148579 |
| 56 | PRKCG | 0.95450718 |
| 57 | PRPF4B | 0.94462566 |
| 58 | MARK1 | 0.94019074 |
| 59 | PTK2 | 0.91404988 |
| 60 | SGK223 | 0.91100871 |
| 61 | SGK494 | 0.91100871 |
| 62 | NLK | 0.88119045 |
| 63 | PDGFRA | 0.86520450 |
| 64 | PIK3CA | 0.86274315 |
| 65 | DAPK2 | 0.85577457 |
| 66 | STK38 | 0.85037396 |
| 67 | BCKDK | 0.84166410 |
| 68 | DMPK | 0.83570866 |
| 69 | FGFR2 | 0.81636539 |
| 70 | CDK5 | 0.81056411 |
| 71 | ROCK1 | 0.79932187 |
| 72 | PRKCH | 0.79458566 |
| 73 | PDK3 | 0.79362174 |
| 74 | PDK4 | 0.79362174 |
| 75 | CAMKK1 | 0.78641441 |
| 76 | GSK3A | 0.78494604 |
| 77 | SGK3 | 0.77354121 |
| 78 | AKT2 | 0.75732768 |
| 79 | PAK2 | 0.74721681 |
| 80 | PAK6 | 0.73344931 |
| 81 | NME1 | 0.71532158 |
| 82 | PRKAA1 | 0.70793369 |
| 83 | NEK9 | 0.69380617 |
| 84 | CAMK2A | 0.67163225 |
| 85 | IGF1R | 0.67036466 |
| 86 | TTN | 0.66725821 |
| 87 | PDPK1 | 0.65995252 |
| 88 | OBSCN | 0.65944557 |
| 89 | MAPK7 | 0.65897480 |
| 90 | PRKCE | 0.65731515 |
| 91 | OXSR1 | 0.63159769 |
| 92 | FER | 0.62911088 |
| 93 | MAP3K13 | 0.60574062 |
| 94 | MAPKAPK5 | 0.60320820 |
| 95 | TRPM7 | 0.59392505 |
| 96 | PRKACB | 0.58392367 |
| 97 | STK39 | 0.58182900 |
| 98 | SGK1 | 0.58137325 |
| 99 | CAMK2G | 0.57939803 |
| 100 | PTK2B | 0.57567146 |
| 101 | ADRBK1 | 0.57560332 |
| 102 | PRKG1 | 0.56988332 |
| 103 | ROCK2 | 0.56917098 |
| 104 | BMX | 0.55752231 |
| 105 | PDGFRB | 0.55286775 |
| 106 | TNK2 | 0.54288261 |
| 107 | PRKD1 | 0.54283244 |
| 108 | PAK4 | 0.53855739 |
| 109 | PRKACG | 0.53031737 |
| 110 | CAMK4 | 0.52991519 |
| 111 | GRK7 | 0.51778310 |
| 112 | WNK1 | 0.51516351 |
| 113 | RPS6KA3 | 0.50629552 |
| 114 | PDK1 | 0.50367421 |
| 115 | NEK6 | 0.49690866 |
| 116 | SRC | 0.49045146 |
| 117 | MAP3K6 | 0.48820366 |
| 118 | PRKACA | 0.47749558 |
| 119 | PKN1 | 0.47553707 |
| 120 | CDC42BPA | 0.47338518 |
| 121 | KSR2 | 0.47288625 |
| 122 | FGFR3 | 0.47127151 |
| 123 | BRAF | 0.45164186 |
| 124 | CAMK2D | 0.44545133 |
| 125 | MAP3K9 | 0.43420326 |
| 126 | MAP2K1 | 0.42370855 |
| 127 | PAK3 | 0.42013818 |
| 128 | CDK6 | 0.41969290 |
| 129 | LIMK1 | 0.41431729 |
| 130 | RET | 0.41015407 |
| 131 | PRKCA | 0.40382795 |
| 132 | CAMK2B | 0.40145605 |
| 133 | CDK3 | 0.40074430 |
| 134 | STK11 | 0.39843857 |
| 135 | IRAK2 | 0.38667157 |
| 136 | MARK2 | 0.38368084 |
| 137 | FGR | 0.37434426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.33055937 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.15900988 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.83120843 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.39411183 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.33121660 |
| 6 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.33007872 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.32882149 |
| 8 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.22212654 |
| 9 | Histidine metabolism_Homo sapiens_hsa00340 | 2.03527391 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.95449937 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.93512336 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 1.90706155 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.90504034 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.78394308 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.74183426 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.70961876 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.64610913 |
| 18 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.63735804 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.62590712 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.54281822 |
| 21 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.49945331 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.49122973 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.44305932 |
| 24 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.34794451 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.33558583 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32182366 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.28643882 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.28073581 |
| 29 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.25903554 |
| 30 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.24514936 |
| 31 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24287750 |
| 32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.23491424 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.21408846 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.21139319 |
| 35 | Circadian rhythm_Homo sapiens_hsa04710 | 1.17593976 |
| 36 | Insulin secretion_Homo sapiens_hsa04911 | 1.16870569 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16277433 |
| 38 | Long-term potentiation_Homo sapiens_hsa04720 | 1.15656847 |
| 39 | Taste transduction_Homo sapiens_hsa04742 | 1.12303567 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.10910600 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.08436020 |
| 42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.06045563 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01718124 |
| 44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.00973446 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99047149 |
| 46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.97679894 |
| 47 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.97088310 |
| 48 | Olfactory transduction_Homo sapiens_hsa04740 | 0.96821332 |
| 49 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.96050173 |
| 50 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.94886794 |
| 51 | Proteasome_Homo sapiens_hsa03050 | 0.94215672 |
| 52 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.93523783 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92491093 |
| 54 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.90579264 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.88933095 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85770093 |
| 57 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.85703857 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 0.85440924 |
| 59 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.85238050 |
| 60 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.84404585 |
| 61 | Cocaine addiction_Homo sapiens_hsa05030 | 0.84014321 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.83553883 |
| 63 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.82821445 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82727165 |
| 65 | Parkinsons disease_Homo sapiens_hsa05012 | 0.82019366 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80868615 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78482813 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77912214 |
| 69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76701950 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75961536 |
| 71 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74675982 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72927835 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.72450166 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71228907 |
| 75 | Gap junction_Homo sapiens_hsa04540 | 0.70099197 |
| 76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69547247 |
| 77 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.68960909 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68902628 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.68308792 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67667335 |
| 81 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67273296 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66413058 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65803966 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65242895 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64614650 |
| 86 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64541424 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64284377 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62952587 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60768775 |
| 90 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59390854 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59258738 |
| 92 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58598954 |
| 93 | Lysine degradation_Homo sapiens_hsa00310 | 0.57603105 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57525349 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57121224 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56683245 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55301367 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.55285407 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53884747 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53730139 |
| 101 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52818463 |
| 102 | Melanogenesis_Homo sapiens_hsa04916 | 0.51695628 |
| 103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.51544925 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50993872 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50352596 |
| 106 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49192699 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.48494832 |
| 108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48246647 |
| 109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.48217220 |
| 110 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46179404 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44977229 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44901887 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44357898 |
| 114 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.43498798 |
| 115 | Focal adhesion_Homo sapiens_hsa04510 | 0.43476753 |
| 116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42164084 |
| 117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.41908152 |
| 118 | Axon guidance_Homo sapiens_hsa04360 | 0.41448393 |
| 119 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.41042321 |
| 120 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.40487762 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39948696 |
| 122 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39288459 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38599429 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38310488 |
| 125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37931159 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37775828 |
| 127 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.37429670 |
| 128 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.37365954 |
| 129 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37087535 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35460406 |
| 131 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34854067 |
| 132 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34679944 |
| 133 | Tight junction_Homo sapiens_hsa04530 | 0.31260986 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30123467 |
| 135 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29816766 |

